These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25930135)

  • 1. Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky.
    Smith RV; Lofwall MR; Havens JR
    Am J Psychiatry; 2015 May; 172(5):487-8. PubMed ID: 25930135
    [No Abstract]   [Full Text] [Related]  

  • 2. Gabapentin misuse, abuse and diversion: a systematic review.
    Smith RV; Havens JR; Walsh SL
    Addiction; 2016 Jul; 111(7):1160-74. PubMed ID: 27265421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.
    Buttram ME; Kurtz SP; Dart RC; Margolin ZR
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1083-1086. PubMed ID: 28493425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse of Gabapentin is Associated with Opioid Addiction.
    Bastiaens L; Galus J; Mazur C
    Psychiatr Q; 2016 Dec; 87(4):763-767. PubMed ID: 26887855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Prescription-Opioid-Impaired and Other Substance-Impaired Drivers in Rural Appalachian Kentucky.
    Webster JM; Dickson MF; Mannan F; Staton M
    J Psychoactive Drugs; 2018; 50(5):373-381. PubMed ID: 30204565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of rural and urban nonmedical prescription opioid users' lifetime and recent drug use.
    Young AM; Havens JR; Leukefeld CG
    Am J Drug Alcohol Abuse; 2012 May; 38(3):220-7. PubMed ID: 22211586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
    Peckham AM; Fairman KA; Sclar DA
    Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky.
    Vickers Smith R; Boland EM; Young AM; Lofwall MR; Quiroz A; Staton M; Havens JR
    Psychol Addict Behav; 2018 Feb; 32(1):115-121. PubMed ID: 29239621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance.
    Throckmorton DC; Gottlieb S; Woodcock J
    N Engl J Med; 2018 Jul; 379(3):205-207. PubMed ID: 29847203
    [No Abstract]   [Full Text] [Related]  

  • 11. Gabapentin dependence in a patient with opioid dependence syndrome.
    Satish R; Kandasamy A; Jayarajan D; Benegal V
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e64. PubMed ID: 25716498
    [No Abstract]   [Full Text] [Related]  

  • 12. Gabapentin and opioid craving.
    Tay KH
    Pain Med; 2009; 10(4):774. PubMed ID: 19453959
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in opioid analgesic abuse and mortality in the United States.
    Dart RC; Surratt HL; Cicero TJ; Parrino MW; Severtson SG; Bucher-Bartelson B; Green JL
    N Engl J Med; 2015 Jan; 372(3):241-8. PubMed ID: 25587948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family member opioid prescriptions and opioid use disorder.
    Ali MM; Henke RM; Mutter R; O'Brien PL; Cutler E; Mazer-Amirshahi M; Pines JM
    Addict Behav; 2019 Aug; 95():58-63. PubMed ID: 30849719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin: can it be misused?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Jan; 52(1):12-5. PubMed ID: 24596960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers.
    Baird CR; Fox P; Colvin LA
    Eur Addict Res; 2014; 20(3):115-8. PubMed ID: 24192603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.
    Peckham AM; Fairman KA; Sclar DA
    Clin Drug Investig; 2017 Aug; 37(8):763-773. PubMed ID: 28451875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance misuse of gabapentin.
    Smith BH; Higgins C; Baldacchino A; Kidd B; Bannister J
    Br J Gen Pract; 2012 Aug; 62(601):406-7. PubMed ID: 22867659
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.
    Keyes KM; Cerdá M; Brady JE; Havens JR; Galea S
    Am J Public Health; 2014 Feb; 104(2):e52-9. PubMed ID: 24328642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.